Revere, MA, United States of America

Gerhard Hannig

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gerhard Hannig: Innovator in Anti-Inflammatory Compounds

Introduction

Gerhard Hannig is a notable inventor based in Revere, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 4 patents to his name, Hannig's work has the potential to impact the treatment of various inflammatory disorders.

Latest Patents

Hannig's latest patents focus on anti-inflammatory compounds and their uses. The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use for treating inflammatory disorders. Additionally, it includes methods for identifying anti-inflammatory compounds and inhibiting NF-κB-dependent target gene expression in a cell. This innovative approach could lead to more effective treatments for patients suffering from inflammatory conditions.

Career Highlights

Gerhard Hannig is affiliated with Yale University, where he continues to advance his research in the pharmaceutical field. His work has garnered attention for its potential applications in medicine, particularly in the realm of inflammatory diseases.

Collaborations

Hannig has collaborated with esteemed colleagues, including Michael J. May and Sankar Ghosh. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.

Conclusion

Gerhard Hannig's contributions to the field of anti-inflammatory compounds demonstrate his commitment to innovation in pharmaceuticals. His work not only showcases his inventive spirit but also holds promise for improving treatment options for inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…